Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study
NCT02542917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2023-04-26
Summary
This trial will test, in a representative group of IBD patients, the acceptability of - and adherence to - the IBDoc test (a new home test for faecal calprotectin in the monitoring of inflammatory bowel disease (IBD)).
Conditions
- Inflammatory Bowel Diseases
- Crohn's Disease
- Ulcerative Colitis
Interventions
- DEVICE
-
IBDoc home test for faecal calprotectin
IBDoc home test for faecal calprotectin
Sponsors & Collaborators
-
King's College Hospital NHS Trust
lead OTHER
Principal Investigators
-
Bu'Hussain Hayee · King's College Hospital NHS Trust
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-07-31
- Completion
- 2016-08-31
More Related Trials
-
Value of Fecal Calprotectin
NCT00577928 ·Status: COMPLETED
-
Are Rates of Colectomies, Resections, Mortalities and Cancer Reduced by Home Monitoring of IBD Patients ?
NCT03038984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
NCT02197780 ·Status: COMPLETED
-
Stratifying Crohn's Using Biomarker Assessment
NCT04321863 ·Status: UNKNOWN
-
Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease
NCT06722456 ·Status: ENROLLING_BY_INVITATION
-
Collection of Specimens for Study of Inflammatory Bowel Disease
NCT00086554 ·Status: COMPLETED
-
Correlation of Fecal Calprotectin and Fecal Immunochemical Test in Determination of Endoscopic Activity in Inflammatory Bowel Disease Patients
NCT06623383 ·Status: COMPLETED
-
Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny
NCT02634060 ·Status: COMPLETED ·Phase: NA
-
Fecal Biomarker Study for Patients With Ulcerative Colitis
NCT00780507 ·Status: COMPLETED
-
Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases
NCT02179372 ·Status: COMPLETED ·Phase: NA
-
The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis
NCT00620126 ·Status: COMPLETED ·Phase: PHASE3
-
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
NCT07177209 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
NCT01666717 ·Status: COMPLETED
-
Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis
NCT02640391 ·Status: COMPLETED
-
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
NCT01759017 ·Status: TERMINATED
-
Evaluation of Faecal Volatile Organic Compounds in the Diagnosis of Paediatric Inflammatory Bowel Disease
NCT03170622 ·Status: COMPLETED
-
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
NCT00968721 ·Status: TERMINATED
-
Nutrition and Clinical Outcomes in IBD
NCT06550310 ·Status: RECRUITING
-
RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis
NCT02822352 ·Status: COMPLETED ·Phase: NA
-
IBDoc® Canadian User Performance Evaluation
NCT03408249 ·Status: COMPLETED ·Phase: NA
-
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
NCT02421705 ·Status: RECRUITING ·Phase: NA
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
NCT03235752 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives
NCT01140802 ·Status: TERMINATED